首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Concise Review: Advances in Generating Hepatocytes from Pluripotent Stem Cells for Translational Medicine
【2h】

Concise Review: Advances in Generating Hepatocytes from Pluripotent Stem Cells for Translational Medicine

机译:简洁评论:从多能干细胞产生肝细胞用于转化医学的研究进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The liver is one of the major organs in the human body. Severe or prolonged exposure of the liver to different factors may cause life‐threatening disease, which necessitates donor organ transplantation. While orthotopic liver transplantation can be used to effectively treat liver failure, it is an invasive procedure, which is severely limited by organ donation. Therefore, alternative sources of liver support have been proposed and studied. This includes the use of pluripotent stem cell‐derived hepatocytes as a renewable source of cells for therapy. In addition to cell‐based therapies, in vitro engineered liver tissue provides powerful models for human drug discovery and disease modeling. This review focuses on the generation of hepatocyte‐like cells from pluripotent stem cells and their application in translational medicine. Stem Cells 2016;34:1421–1426
机译:肝脏是人体的主要器官之一。肝脏严重或长期暴露于不同因素下可能会导致威胁生命的疾病,这需要供体器官移植。尽管原位肝移植可用于有效治疗肝衰竭,但这是一种侵入性手术,受到器官捐赠的严重限制。因此,已经提出并研究了肝脏支持的替代来源。这包括使用多能干细胞来源的肝细胞作为治疗细胞的可再生来源。除了基于细胞的疗法之外,体外工程化的肝组织还为人类药物发现和疾病建模提供了强大的模型。这篇综述着重于多能干细胞的肝细胞样细胞的产生及其在转化医学中的应用。干细胞2016; 34:1421-1426

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号